Replies to post #16168 on Cytodyn Inc (CYDY)

[Grip it and Sip It]

I agree Saltz and Chump! What's a few pennies between friends! :)

Here is an interesting article on CNN.com this morning. I must admit I'm nervous we are being myopic in the glee of PRO140's possibilities when it's clear this is a much more competitive market space. I read this article anxiously awaiting the words PRO140 and didnsee anything alluding to this disruptive therapy. If there is a plan, it better be on a more rapid trajectory. Sending PR's on iHub can't compete with millions of eyes seeing it on CNN. I apologize in advance for some of the R-Rated inferences in the study. The silver lining is that AIDS groups are clearly advocating treatments that suppress viral loads which they feel stops transmission.

I hope they just sell this and fast! They don't have the time to wait. Larger BP will get there quicker with deeper pockets. Let's not get greedy! IMO

Grip


Results from a recent vaccine trial, known as the APPROACH trial, were presented at the conference Monday and revealed this type of vaccine could instigate an immune response against HIV when tested on almost 400 volunteers across five countries.
The type used were mosaic vaccines, where components of different HIV viruses are combined together to create an immune response in the body.
Seven different regimens of the vaccine were tested and all elicited an immune response and were well tolerated in the body. One that previously showed promise in animals shined through, giving the strongest response in humans.
The researchers stress, however, that simply because an immune response was created does not mean it will prevent someone becoming infected with HIV.
"The promising, early-stage results from the APPROACH study support further evaluation of these candidate vaccines to assess their ability to protect those at risk of acquiring HIV," said Dr. Dan Barouch, a principal investigator for APPROACH, in a statement.
"A safe and effective HIV vaccine would be a powerful tool to reduce new HIV infections worldwide and help bring about a durable end to the HIV/AIDS pandemic," said Fauci, whose institute supported the trial. "By exploring multiple promising avenues of vaccine development research, we expand our opportunities to achieve these goals."
Bekker added that this is one of three avenues currently being explored to create an effective vaccine against HIV, including one being trialed in her home country, South Africa. Whichever one wins the race, it can't come fast enough.
"Finally, a vaccine will clean (HIV infections) up" after these prevention services are in place, she said. "And hopefully eliminate HIV

[Grip it and Sip It]

Saltz-

I look forward to your commentary and take heed in your information that appears to be coming from reliable sources. I'm beginning to wonder if those on the inside aren't playing games or just pacifying investors.

So far this morning I jumped in at $.75, watched it drop to $.73 and there's a 200k+ share ask at $.75!

Someone with that many shares must be getting the same info you are however they are willing to part with that many shares being so close to this PR?

I've been in for almost a year and it's the same song from leadership. Pretty soon, it's gonna be "put up or shut up" time for them.

This isn't a critique because you are very well-versed in what's going on but people may be acting in that as much as they may be acting on Pears "doom and gloom"

In short, these predictions are meaningless until Tony and his team learn to be communicative with us!

Thanks for listening!

Grip